| Symbol | FATE |
|---|---|
| Name | FATE THERAPEUTICS INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 12278 SCRIPPS SUMMIT DRIVE, SAN DIEGO, CA 92131 |
| Telephone | 858.875.1803 |
| Fax | — |
| — | |
| Website | https://www.fatetherapeutics.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001434316 |
| Description | Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and immune disorders. The companys cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients. Additional info from NASDAQ: |
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Read moreFate Therapeutics to Present Preliminary Clinical Data of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Sclerosis at the ISSCR 2026 Annual Meeting
Read moreFate Therapeutics to Participate in Upcoming Third Quarter 2026 Conferences
Read moreDirector Lee Michael Stewart 🟢 acquired 87.9K shares (1 derivative) of FATE THERAPEUTICS INC (FATE) at $2.06 Transaction Date: Jun 12, 2026 | Filing ID: 074126
Read moreXu Yuan 🟢 acquired 87.9K shares (1 derivative) of FATE THERAPEUTICS INC (FATE) at $2.06 Transaction Date: Jun 12, 2026 | Filing ID: 271090
Read moreJooss Karin 🟢 acquired 87.9K shares (1 derivative) of FATE THERAPEUTICS INC (FATE) at $2.06 Transaction Date: Jun 12, 2026 | Filing ID: 271088
Read moreEPSTEIN ROBERT S 🟢 acquired 87.9K shares (1 derivative) of FATE THERAPEUTICS INC (FATE) at $2.06 Transaction Date: Jun 12, 2026 | Filing ID: 271083
Read moreAgarwal Shefali 🟢 acquired 87.9K shares (1 derivative) of FATE THERAPEUTICS INC (FATE) at $2.06 Transaction Date: Jun 12, 2026 | Filing ID: 271079
Read moreABERNETHY MATT 🟢 acquired 87.9K shares (1 derivative) of FATE THERAPEUTICS INC (FATE) at $2.06 Transaction Date: Jun 12, 2026 | Filing ID: 271074
Read moreRASTETTER WILLIAM H 🟢 acquired 87.9K shares (1 derivative) of FATE THERAPEUTICS INC (FATE) at $2.06 Transaction Date: Jun 12, 2026 | Filing ID: 271072
Read more